For Chip Makers, the Flip from Shortage to Glut Intensifies
Editor's Pick
Mainz Biomed Reports Breakthroughs in Non-Invasive Cancer Testing
April 24th, 2025 – Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company, is emerging as a formidable force…
From IoT to the Innovation of Issues: A Dialog with Jared Deith, EVP & CRO at KORE
On this Q&A, Jared Deith, EVP and Chief Income Officer at KORE,…
Reversing Diabetes Without Medication: Dr. Chris Chappel’s Revolutionary Method at Evergreen Doctors
For decades, type 2 diabetes has been viewed as a lifelong condition,…
Oponion
Razor-thin Home majority has the GOP sweating
Home Republican management is hanging on by a thread, struggling…